Spatially restricted antigen expression by an ionizable lipid nanoparticle enhances mRNA vaccine immunity against Pseudomonas aeruginosa
Journal of Controlled Release · 2026-11 · 399 · 115306
DOI: 10.1016/j.jconrel.2026.115306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Nana Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Provincial Key Laboratory of Inno…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Antigens, Bacterial, Pseudomonas Infections, Lipids. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Guizhou Medical University, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Pseudomonas aeruginosa is a major cause of hospital-acquired infections, yet no licensed vaccine is available. Although mRNA-LNP vaccines offer a flexible platform for antibacterial immunization, conventional formulations are primarily optimized for gene expression and often result in systemic antigen distribution. Here, we developed a novel ionizable lipid, LC3, that enables spatially confined antigen expression following intramuscular administration while enhancing immunostimulatory activity. Compared with SM102-based LNPs, mRNA-LNPLC3 achieved preferential antigen expression at the injection site and draining lymph nodes, with reduced hepatic expression. Mechanistic studies revealed a pronounced decoupling between cellular uptake and productive gene expression, where LC3-based LNPs showed comparable uptake but cell-context-dependent expression differences between hepatocytes and muscle cells, indicating that intracellular processing rather than uptake efficiency governs functional expression and underlies the liver-sparing profile. Single-cell RNA sequencing demonstrated that LNPLC3 vaccination induced a coordinated early immune activation program. Functionally, LNPLC3 elicited stronger humoral and cellular immune responses than LNPSM102 and conferred improved protection against P. aeruginosa, while maintaining a favorable safety profile. Collectively, these results demonstrate that LC3 enables spatially restricted antigen expression through cell-context-dependent intracellular processing, linking localized expression to enhanced immunostimulatory activity. LC3-based LNPs therefore integrate spatial control of antigen expression with improved immune activation, providing a rational strategy for mRNA-LNP vaccine design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Provincial Key Laboratory of Innovation and Manufacturing for Pharmaceuticals, School of Pharmaceutical…
- Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, PR China.
- Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Medical University, Hefei, Anhui 230032, PR China.
- Key Laboratory of Medical Molecular Virology of MOE/NHC/CAMS, School of Basic Medical Sciences & Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, PR China.
- Department of Emergency Surgery, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230001, PR China. Electronic address: sunyuansong@ahmu.edu.cn.
- Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, PR China; State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Shanghai 201203, PR China.…
Förderung
- Guizhou Medical University
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Zhang, N., Sun, Z., Fan, L., Miao, Y., Wei, A., Gao, X., Zhang, J., Sun, Y., & Wei, X. (2026). Spatially restricted antigen expression by an ionizable lipid nanoparticle enhances mRNA vaccine immunity against Pseudomonas aeruginosa. Journal of Controlled Release, 399, 115306. https://doi.org/10.1016/j.jconrel.2026.115306
Vancouver
Zhang N, Sun Z, Fan L, Miao Y, Wei A, Gao X, et al. Spatially restricted antigen expression by an ionizable lipid nanoparticle enhances mRNA vaccine immunity against Pseudomonas aeruginosa. Journal of Controlled Release. 2026;399:115306. doi:10.1016/j.jconrel.2026.115306
BibTeX
@article{Zhang2026,
author = {Zhang, Nana and Sun, Ziwei and Fan, Lianfeng and Miao, Yu and Wei, Anqi and Gao, Xihui and Zhang, Jiquan and Sun, Yuansong and Wei, Xiaoli},
title = {Spatially restricted antigen expression by an ionizable lipid nanoparticle enhances mRNA vaccine immunity against Pseudomonas aeruginosa},
journal = {Journal of Controlled Release},
year = {2026},
volume = {399},
pages = {115306},
doi = {10.1016/j.jconrel.2026.115306}
}
EUVIMED